68Ga-Prgd2 PET/CT for Αvβ3-Integrin Receptor Imaging of Post-Stroke Angiogenesis: A Pilot Clinical Study
Yi Sun,Zhaohui Zhu,Xiaoyuan Chen,Fang Li
2013-01-01
Abstract:157 Objectives Therapeutic angiogenesis holds a promise to re-establish blood supply and revise brain function for stroke patients. However, the clinical translation lack an objective endpoint to quantitatively evaluate angiogenesis in vivo. This clinical trial was designed to evaluate post-stroke angiogenesis using a novel PET tracer, 68Ga-PRGD2, which was compared with CT, MRI, and 18F-FDG PET/CT within a week. Methods Seven stroke patients (M 6, F 2, 37-81y) within 2 weeks to 13 years after the stroke attack were recruited with informed consent. Thirty minutes after intravenous injection of nearly 111 MBq (3 mCi) of 68Ga-PRGD2, the patients underwent a 10-minute brain PET/CT. The 18F-FDG PET/CT and MRI were performed within a week for comparison. The 68Ga-PRGD2 images were matched and fused with CT, MRI, and 18F-FDG PET images for visual and semi-quantitative analysis. By referring to the CT and/or MRI images, the standardized uptake value (SUV) of 68Ga-PRGD2 and 18F-FDG at the peri-stroke regions were measured and compared to those of the contralateral normal cerebrum. Results Apparent 68Ga-PRGD2 accumulation was observed at the peri-stroke regions in 2 patients in the fourth week after a severe stroke. There was no correlation between the 68Ga-PRGD2 accumulation and the 18F-FDG uptake at the stroke and peri-stroke regions. Two of the 5 patients without obvious 68Ga-PRGD2 uptake were in their second week after the stroke attack but had less severe symptoms. They showed smaller infarction area with the longest diameter less than 3 mm on MRI. The other 3 patients were in 4-13 years after stroke attack, and none had 68Ga-PRGD2 accumulation but all showed 18F-FDG uptake defect. Conclusions αvβ3-integrin receptor imaging using 68Ga-PRGD2 PET/CT may be useful for evaluation of post-stroke repair by providing information related to angiogenesis. The success of this pilot study merits further clinical investigation of 68Ga-PRGD2 PET/CT in evaluation of stroke patients.
What problem does this paper attempt to address?